TRANSBORO
Pioneering Innovation in Cancer Treatment Brick42 is proud to be a key partner in TRANSBORO, a groundbreaking cross-border initiative under the Interreg VI-A Italy-Switzerland 2021-2027 Programme. This collaboration unites top institutions from Italy and Switzerland to revolutionize oncology through cutting-edge Continue reading TRANSBORO